Biotage AB (publ) publishes Annual and Sustainability Report 2024

Contacts

Frederic Vanderhaegen, President and CEO

Andrew Kellett, CFO

About Biotage

Biotage is a global supplier and solutions partner to a wide range of customers within Drug Discovery and Development and Analytical Testing. With expertise in separation and purification technology and leveraging intelligent workflow solutions, the group aims to efficiently enable further advancement and protection of human health.

Headquartered in Sweden, Biotage operates globally with 700 employees and serves customers in 80 countries. Our company is listed on NASDAQ Stockholm (BIOT).
Website: www.biotage.com

This information is information that Biotage is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-04-03 13:00 CEST.

Attachments

Biotage Annual And Sustainability Report 2024
biotageab-2024-12-31-0-sv